Exploring the Role of the TL1A-DR3 Pathway in Hidradenitis Suppurativa - Takeaways - MDSpire

Exploring the Role of the TL1A-DR3 Pathway in Hidradenitis Suppurativa

  • By

  • Juling Sia

  • Bernett Lee

  • Hazel H. Oon

  • April 22, 2026

  • 0 min

Share

  • 1

    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder with significant comorbidities and impacts on quality of life.

  • 2

    Current HS treatments often fail, necessitating a combination of antibiotics, biologics, and sometimes surgical interventions.

  • 3

    The TL1A-DR3 signaling pathway is implicated in HS pathogenesis, influencing immune cell activity and fibrosis.

  • 4

    Anti-TL1A therapies, such as tulisokibart, are being evaluated for their efficacy in treating moderate-to-severe HS.

  • 5

    This review highlights the need for further research on the TL1A-DR3 axis and its role in HS to inform future clinical studies.

Original Source(s)

Exploring the Role of the TL1A-DR3 Pathway in Hidradenitis Suppurativa

  • by Juling Sia, Bernett Lee, Hazel H. Oon

  • April 22, 2026

Related Content

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

When Obesity Meets Infection Risk

Researchers analyze data from Finnish cohorts and the UK Biobank to examine how body mass index relates to severe infections and their global burden.

Psychiatric and Psychological Care Utilization Among Patients with Atopic Dermatitis, Hidradenitis Suppurativa, and Psoriasis: Insights from a Propensity-Matched Real-World Cohort Analysis